Conning’s BeOne Medicines ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
Conning's ONC Position: Q4 2017 in Review
Conning sold out of BeOne Medicines (ONC) in Q4 2017, closing a stake of 53,451 shares — an estimated $5.53M sold.
Conning first reported a position in ONC in Q4 2016 and held it in 4 quarters. The position peaked at $5.9M in Q1 2017. 93 funds tracked by Wall St. Rank hold ONC as of Q4 2017.
- Conning reported no remaining BeOne Medicines position as of Q4 2017 after selling out during the quarter.
- Conning sold 53,451 BeOne Medicines shares in Q4 2017, an estimated $5.53M.
- Conning first reported a position in BeOne Medicines in Q4 2016 and held it in 4 quarters.
- Conning's BeOne Medicines position peaked at $5.9M in Q1 2017.
- 93 funds tracked by Wall St. Rank held BeOne Medicines as of Q4 2017.
Based on Conning's 13F filing for Q4 2017, filed 30 Jan 2018.